Hi John,
1. Is NV going to have a CTO named?
JH) There are several different titles that can be given the one who
directs the activities of an engineering project. CTO is one title that
includes being a corporate officer. Our project will not lack for
leadership and there will come a time that naming a CTO will be appropriate.
2. If not why not?
3. We have been told in order for media to believe in us we need
credibility.
I would think if we had named Greaves as CTO that would have opened us up to
the media and the industry taking us seriously. And yes I do realize he was
named to the advisory board. But in the business world and wallstreet.
Perception is everything.
That being said. And the PR today not listing Greaves to the CTO position.
How will we obtain that perception now?
JH) Are you suggesting that because we did not name Dr. Greaves as CTO,
all is lost? Our primary objective is commercializing our technology. We
believe that the role Dr. Greaves is playing is of more value to us than the
value would be of naming him CTO. We also believe that nothing has been
lost in our credibility campaign with the industry. If you will re-read
your previous paragraph, it is apparent that the media and perceptions are
the most important objectives. If you were to shift your objectives to
commercializing and selling to the telcos a new transmission technique, you
would be forced to establish a new set of priorities. Those new priorities
would permit the evaluation of our progress as measured by our associates
rather than by the current share price. Remember, over 80% of our share
price is totally outside our control, subject to overall market conditions.
Our associations are totally within our control so that is what we focus on.
4. Are we going to any fall trade shows?
JH) We are and will be making our presence known at the appropriate
industry gatherings.
5. Are we still on pace for fourth quarter revenues?
JH) We remain confident.
6. Could you please expand on the role of Adaptive? Are we helping them? Or
they helping us? Or well it be a mutual benefit?
JH) Dr. Propp and his assembled intellectual talent are being very helpful
to us in our commercialization efforts. We anticipate their contributions
to become even more important over time.
7. Can you confirm either yes or no if they are working on Cu@OCx for use
over powerlines?
JH) That is not the focus of the current project.
8. When does NV expect beta testing to take place. I know you don't like to
give out timelines. So how about we call this an estimated timeline?
JH) Our new engineering team has been working with us a short time. A
more accurate estimate of the timelines will be possible, but not quite yet.
9. Is Greaves writing the white papers? If so can you give an estimated
timeline of release to the industry?
JH) Dr. Greaves will be producing additional technical papers and will
result in white papers for public viewing. Any technical papers that the
industry views will be under NDA.
10. Would it make sense that whoever we are developing technology for right
now we'd be sharing a lab with them?
JH) That makes sense.
Excel - Greg
News 
Market Data 
Discover 
